Home » EPIC Archives: AVCT

AVCT News Archives

Overview of pre|CISION™ prodrug technology

Avacta Group Plc

Alastair Smith provides overview of pre|CISIONTM prodrug technology and update on AVA6000 clinical trial Avacta Group Plc (LON:AVCT) offers reagents and therapeutics based on Affimer technology for diagnostic and research applications ...

Read Article »

Avacta Group to hold Analyst Briefing

Avacta Group Plc

Avacta Group plc (LON:AVCT), the developer of Affimer® biotherapeutics and reagents, will announce its financial results for the 17 months ended 31 December 2019 on Tuesday, 21 April 2020. An analyst briefing given ...

Read Article »

Avacta featured on BBC Look North

Avacta Group Plc

Avacta Group has been featured on BBC Look North. Our Chief Executive Officer Alastair Smith gave a brief interview, explaining to the BBC the oncology work being undertaken. Avacta Group ...

Read Article »